LeMaitre Vascular, Inc. (LMAT)
78.87
-0.60
(-0.76%)
USD |
NASDAQ |
Sep 18, 16:00
78.76
-0.11
(-0.14%)
After-Hours: 20:00
LeMaitre Vascular Market Cap : 1.803B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.803B |
| September 17, 2026 | 1.817B |
| September 16, 2026 | 1.838B |
| September 15, 2026 | 1.835B |
| September 14, 2026 | 1.847B |
| September 11, 2026 | 1.843B |
| September 10, 2026 | 1.802B |
| September 09, 2026 | 1.817B |
| September 08, 2026 | 1.820B |
| September 04, 2026 | 1.845B |
| September 03, 2026 | 1.840B |
| September 02, 2026 | 1.869B |
| September 01, 2026 | 1.854B |
| August 31, 2026 | 1.836B |
| August 28, 2026 | 1.839B |
| August 27, 2026 | 1.822B |
| August 26, 2026 | 1.820B |
| August 25, 2026 | 1.806B |
| August 24, 2026 | 1.828B |
| August 21, 2026 | 1.872B |
| August 20, 2026 | 1.882B |
| August 19, 2026 | 1.918B |
| August 18, 2026 | 1.864B |
| August 17, 2026 | 1.887B |
| August 14, 2026 | 1.884B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.873B |
| August 12, 2026 | 1.878B |
| August 11, 2026 | 1.894B |
| August 10, 2026 | 1.856B |
| August 07, 2026 | 1.862B |
| August 06, 2026 | 1.848B |
| August 05, 2026 | 1.806B |
| August 04, 2026 | 2.419B |
| August 03, 2026 | 2.369B |
| July 31, 2026 | 2.317B |
| July 30, 2026 | 2.337B |
| July 29, 2026 | 2.368B |
| July 28, 2026 | 2.339B |
| July 27, 2026 | 2.262B |
| July 24, 2026 | 2.186B |
| July 23, 2026 | 2.229B |
| July 22, 2026 | 2.259B |
| July 21, 2026 | 2.300B |
| July 20, 2026 | 2.325B |
| July 17, 2026 | 2.324B |
| July 16, 2026 | 2.356B |
| July 15, 2026 | 2.282B |
| July 14, 2026 | 2.238B |
| July 13, 2026 | 2.293B |
| July 10, 2026 | 2.349B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 62.70B |
| Abbott Laboratories | 177.55B |
| AngioDynamics, Inc. | 643.85M |
| Alphatec Holdings, Inc. | 1.554B |
| AtriCure, Inc. | 2.955B |
Market Cap Related Metrics
| PE Ratio | 28.10 |
| PS Ratio | 7.132 |
| PEG Ratio | 0.7733 |
| Price to Book Value | 4.290 |
| Price to Free Cash Flow | 25.35 |
| Price | 78.87 |
| Earnings Yield | 3.56% |
| PEGY Ratio | 0.7485 |
| Operating PE Ratio | 24.21 |
| Normalized PE Ratio | 28.10 |